Agios Pharma (AGIO) Q1 2026 Earnings Report
MX:AGIO Q1 2026 EPS Results
- Actual EPS
- -MXN 31.40
- Consensus EPS
- -MXN 33.50
- Beat/Miss
- Beat by +MXN 2.10
- One Year Ago EPS
- -MXN 28.80
MX:AGIO Q1 2026 Revenue Results
- Actual Revenue
- MXN 385.48M
- Expected Revenue
- MXN 247.14M
- Beat/Miss
- Beat by +MXN 138.33M
- YoY Revenue Growth
- +137.75%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/29/2026
- Time
- Before Open
- Conference Call
- Wednesday, April 29, 2026
MX:AGIO Upcoming Earnings
Agios Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:AGIO Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:AGIO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -23.11- | -33.07 | ― | ― |
| Jul 30, 2026 | 2026 (Q2) | -30.75-31.40 | -35.86 | 12.44% (+4.46) | |
| Apr 29, 2026 | 2026 (Q1) | -33.50-31.40 | -28.8 | -9.03% (-2.60) | |
| Feb 12, 2026 | 2025 (Q4) | -36.31-34.56 | -26.76 | -29.17% (-7.80) | |
| Oct 30, 2025 | 2025 (Q3) | -35.25-33.07 | 301.38 | -110.97% (-334.45) | |
| Jul 31, 2025 | 2025 (Q2) | -33.58-35.86 | -31.4 | -14.20% (-4.46) | |
| May 01, 2025 | 2025 (Q1) | -32.91-28.80 | -26.94 | -6.90% (-1.86) | |
| Feb 13, 2025 | 2024 (Q4) | -31.42-26.76 | -31.77 | 15.79% (+5.02) | |
| Oct 31, 2024 | 2024 (Q3) | 282.73301.38 | -30.47 | 1089.02% (+331.85) | |
| Aug 01, 2024 | 2024 (Q2) | -29.77-31.40 | -28.06 | -11.92% (-3.34) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
